Cellid, Co., Ltd. (299660.KQ)

KRW 5500.0

(-7.25%)

Total Assets Summary of Cellid, Co., Ltd.

Cellid, Co., Ltd.'s latest annual total assets in 2023 was 63.92 Billion KRW , up 39.39% from previous year.
Cellid, Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 53.69 Billion KRW , down -13.9% from previous quarter.
Cellid, Co., Ltd. reported annual total assets of 45.85 Billion KRW in 2022, down -21.28% from previous year.
Cellid, Co., Ltd. reported annual total assets of 58.25 Billion KRW in 2021, up 17.93% from previous year.
Cellid, Co., Ltd. reported quarterly total assets of 53.69 Billion KRW for 2024 Q2, down -13.9% from previous quarter.
Cellid, Co., Ltd. reported quarterly total assets of 31.04 Billion KRW for 2023 Q2, down -10.98% from previous quarter.

Annual Total Assets Chart of Cellid, Co., Ltd. (2023 - 2015)

Historical Annual Total Assets of Cellid, Co., Ltd. (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	63.92 Billion KRW	39.39%
2022	45.85 Billion KRW	-21.28%
2021	58.25 Billion KRW	17.93%
2020	49.39 Billion KRW	-5.93%
2019	52.51 Billion KRW	269.41%
2018	14.21 Billion KRW	186.43%
2017	4.96 Billion KRW	30.33%
2016	3.8 Billion KRW	34.39%
2015	2.83 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	62.36 Billion KRW	-2.44%
2024 Q2	53.69 Billion KRW	-13.9%
2023 Q2	31.04 Billion KRW	-10.98%
2023 Q1	34.87 Billion KRW	-23.95%
2023 Q4	63.92 Billion KRW	24.68%
2023 Q3	51.26 Billion KRW	65.14%
2023 FY	63.92 Billion KRW	39.39%
2022 Q4	45.85 Billion KRW	-2.32%
2022 Q2	49.66 Billion KRW	-6.36%
2022 FY	45.85 Billion KRW	-21.28%
2022 Q1	53.03 Billion KRW	-8.96%
2022 Q3	46.94 Billion KRW	-5.48%
2021 Q2	64.79 Billion KRW	-2.71%
2021 FY	58.25 Billion KRW	17.93%
2021 Q3	61.93 Billion KRW	-4.41%
2021 Q4	58.25 Billion KRW	-5.95%
2021 Q1	66.6 Billion KRW	34.83%
2020 Q1	51.86 Billion KRW	-1.24%
2020 Q2	51.17 Billion KRW	-1.33%
2020 FY	49.39 Billion KRW	-5.93%
2020 Q3	50.04 Billion KRW	-2.22%
2020 Q4	49.39 Billion KRW	-1.28%
2019 FY	52.51 Billion KRW	269.41%
2019 Q3	54.86 Billion KRW	1.71%
2019 Q1	54.55 Billion KRW	283.75%
2019 Q4	52.51 Billion KRW	-4.28%
2019 Q2	53.93 Billion KRW	-1.13%
2018 Q1	- KRW	-100.0%
2018 FY	14.21 Billion KRW	186.43%
2018 Q2	16.23 Billion KRW	0.0%
2018 Q4	14.21 Billion KRW	0.0%
2017 FY	4.96 Billion KRW	30.33%
2017 Q1	- KRW	0.0%
2017 Q4	4.96 Billion KRW	0.0%
2016 FY	3.8 Billion KRW	34.39%
2015 FY	2.83 Billion KRW	0.0%

Peer Total Assets Comparison of Cellid, Co., Ltd.

Name	Total Assets	Total Assets Difference
Sam Chun Dang Pharm. Co., Ltd	408.02 Billion KRW	84.334%
Hyundai Bioscience Co., Ltd.	52.79 Billion KRW	-21.084%
ST Pharm Co.,Ltd.	686.83 Billion KRW	90.693%
ABL Bio Inc.	160.14 Billion KRW	60.085%